Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Details)

v3.20.2
Segment Information (Details)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2020
USD ($)
Jun. 30, 2020
USD ($)
Mar. 31, 2020
USD ($)
Sep. 30, 2019
USD ($)
Jun. 30, 2019
USD ($)
Mar. 31, 2019
USD ($)
Sep. 30, 2020
USD ($)
segment
Sep. 30, 2019
USD ($)
Dec. 31, 2019
USD ($)
Segment Reporting [Abstract]                  
Number of operating segments | segment             2    
Segment Reporting Information [Line Items]                  
Total revenue $ 125,444     $ 104,672     $ 318,451 $ 301,962  
Total cost of revenue 71,379     53,840     190,011 155,049  
Total gross profit 54,065     50,832     128,440 146,913  
General and administrative 36,128     33,054     107,085 94,773  
Research and development 1,964     2,611     6,129 6,407  
Sales and marketing 11,304     11,508     34,757 35,048  
Total operating expenses 49,396     47,173     147,971 136,228  
Income (loss) from operations 4,669     3,659     (19,531) 10,685  
Interest expense, net 2,458     203     4,825 3,333  
Other (income) expense, net (11)     (35)     (7,639) 5,124  
Loss on extinguishment of debt 0     0     1,400 1,018 $ 1,400
Loss on termination of cash flow hedge 0     0     3,506 0  
Income (loss) before taxes 2,222     3,491     (21,623) 1,210  
Income tax (benefit) expense (335)     1,348     (10,378) (500)  
Net income (loss) 2,557 $ (6,824) $ (6,978) 2,143 $ 1,991 $ (2,424) (11,245) 1,710  
Clinical Services                  
Segment Reporting Information [Line Items]                  
Total revenue 108,733     92,565     275,599 267,757  
Total cost of revenue 60,607     47,526     158,287 136,557  
Total gross profit 48,126     45,039     117,312 131,200  
Pharma Services                  
Segment Reporting Information [Line Items]                  
Total revenue 16,711     12,107     42,852 34,205  
Total cost of revenue 10,772     6,314     31,724 18,492  
Total gross profit $ 5,939     $ 5,793     $ 11,128 $ 15,713